Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer’s disease Andrea SchmittPeter Falkai Editorial 30 April 2013 Pages: 271 - 272
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors Alkomiet HasanAmanda MitchellSchahram Akbarian Invited Review 05 February 2013 Pages: 273 - 284
Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain Nina PeselmannAndrea SchmittMathias Zink Original Paper 12 September 2012 Pages: 285 - 297
Insight in schizophrenia: associations with empathy G. H. M. PijnenborgJ. M. SpikmanA. Aleman Original Paper 18 October 2012 Pages: 299 - 307
High rehospitalization rate in alcohol-induced psychotic disorder Michael SoykaBernd HeltenPeggy Schmidt Original Paper 01 November 2012 Pages: 309 - 313
Brain perfusion asymmetry in patients with oral somatic delusions Yojiro UmezakiAyano KatagiriAkira Toyofuku Original Paper Open access 29 January 2013 Pages: 315 - 323
The National Institute on Aging-Alzheimer’s Association research criteria for mild cognitive impairment due to Alzheimer’s disease: predicting the outcome Liang-Hao GuoPanagiotis AlexopoulosRobert Perneczky Original Paper 30 August 2012 Pages: 325 - 333
Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer’s disease Sönke ArltRalph BuchertHolger Jahn Original Paper 01 September 2012 Pages: 335 - 344
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls Markus J. SchwarzGilles J. GuilleminHarald Hampel Original Paper 29 November 2012 Pages: 345 - 352
The psychiatric interview: validity, structure, and subjectivity Julie NordgaardLouis A. SassJosef Parnas Original Paper Open access 23 September 2012 Pages: 353 - 364